Inflammasome Targeting in Ocular & Neurodegenerative Disease

Time: 9:30 am
day: Day Two

Details:

  • Connexin hemichannel regulation prevents ATP induced activation of the inflammasome
  • Connexin hemichannel regulation on its own is sufficient to shut down the inflammasome in ocular and neurodegenerative disease
  • InflammX Therapeutics clinical trial plans and progress

Speakers: